Tag:
Xigris
Latest Headlines
Latest Headlines
Lilly CEO vows to steer clear of Abbott, stick with deals and alliances
Eli Lilly ( $LLY ) had a fresh blast of bad news to report today when it announced that an absence of efficacy data is forcing it to withdraw Xigris from the market. But don't expect problems either on
Lilly pulls Xigris on failed septic-shock study
Say goodbye to Eli Lilly's ill-fated sepsis drug Xigris. Results of a new study showed that the drug didn't help patients with septic shock live any longer than a placebo did, so Lilly is pulling it.
Lilly launches new venture to market Xigris
What to do with an underperforming drug? If you're Eli Lilly, you start a new company to sell it. The Indianapolis-based company has licensed the U.S. rights to Xigris , a treatment for sepsis, to
Lilly spins off sepsis drug into a biotech start-up
Eli Lilly has inked a deal with a pair of investors--Care Capital and NovaQuest Capital--to spin off a sepsis drug into a new biotech in Indiana dubbed BioCritica which plans to build a pipeline of
